Impel Neuropharma Inc (IMPL)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Adrian Adams
Employees:
201 ELLIOTT AVE. W, SUITE 260, SEATTLE, WA 98119
206-568-1466

We are a late-stage pharmaceutical company focused on utilizing our proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system, or CNS. We were incorporated under the laws of the State of Delaware in July 2008. Our principal executive offices are located at 201 Elliott Avenue West, Suite 260, Seattle, Washington.

Data derived from most recent annual or quarterly report
Market Cap 193.926 Million Shares Outstanding19.51 Million Avg 30-day Volume 516.103 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 34.75 / 6.9 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

View recent insider trading info

Funds Holding IMPL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMPL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

73.4 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LEAMAN JOHN HAROLD CHIEF FIN. & BUSINESS OFFICER

  • Officer
10,571 2021-10-19 2

SHREWSBURY STEPHEN B CHIEF MEDICAL OFFICER

  • Officer
103,512 2021-09-21 2

ADAMS ADRIAN COB, CEO AND PRESIDENT

  • Officer
  • Director
20,000 2021-08-18 2

PAOLILLO LEONARD CHIEF COMMERCIAL OFFICER

  • Officer
30,000 2021-07-20 1

HOEKMAN JOHN CHIEF SCIENTIFIC OFFICER

  • Officer
50,000 2021-07-20 3

PARKER H STEWART

  • Director
11,500 2021-07-11 5

NELSON TIMOTHY S

  • Director
11,500 2021-07-11 1

SHAH MAHENDRA

  • Director
11,500 2021-07-11 1

WILFONG DIANE E.

  • Director
11,500 2021-07-11 1

ALLISON DAVID D.

  • Director
11,500 2021-07-11 1

KKR IRIS INVESTORS LLC

KKR HEALTHCARE STRATEGIC GROWTH FUND L.P.

KKR ASSOCIATES HCSG L.P.

KKR HCSG GP LLC

KKR GROUP PARTNERSHIP L.P.

KKR GROUP HOLDINGS CORP.

KKR & CO. INC.

KKR MANAGEMENT LLP

KRAVIS HENRY R

ROBERTS GEORGE R

3,802,638 2021-04-27 1

NORWEST VENTURE PARTNERS XIV, LP

CROWE JEFFREY

HAQUE PROMOD

KOSSOW JON ERIK

  • 10% Owner
3,077,198 2021-04-27 2

5AM VENTURES V, L.P.

5AM PARTNERS V, LLC

PARMAR KUSH

ROCKLAGE SCOTT M

SCHWAB ANDREW J.

5AM OPPORTUNITIES I, L.P.

5AM OPPORTUNITIES I (GP), LLC

  • 10% Owner
2,884,791 2021-04-27 2

VENBIO GLOBAL STRATEGIC FUND II L.P.

VENBIO GLOBAL STRATEGIC GP II, L.P.

VENBIO GLOBAL STRATEGIC GP II, LTD.

GOODMAN COREY S

ADELMAN ROBERT J

2,759,791 2021-04-27 2

VIVO CAPITAL VIII, LLC

VIVO CAPITAL FUND VIII, L.P.

VIVO CAPITAL SURPLUS FUND VIII, L.P.

  • 10% Owner
2,884,789 2021-04-27 2

5AM VENTURES V, L.P.

5AM PARTNERS V, LLC

PARMAR KUSH

ROCKLAGE SCOTT M

SCHWAB ANDREW J.

  • 10% Owner
1,359,799 2021-04-22 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LEAMAN JOHN HAROLD - Officer CHIEF FIN. & BUSINESS OFFICER

2021-10-21 17:31:01 -0400 2021-10-19 A 10,571 a 10,571 direct

SHREWSBURY STEPHEN B - Officer CHIEF MEDICAL OFFICER

2021-09-22 16:57:49 -0400 2021-09-21 M 14,780 $1.97 a 14,780 direct -3.1227 -9.4424 5.2788 4 -9.4424 6

SHREWSBURY STEPHEN B - Officer CHIEF MEDICAL OFFICER

2021-09-22 16:57:49 -0400 2021-09-21 M 53,954 d 29,587 direct

SHREWSBURY STEPHEN B - Officer CHIEF MEDICAL OFFICER

2021-09-22 16:57:49 -0400 2021-09-21 M 53,954 $2.95 a 73,384 direct -3.1227 -9.4424 5.2788 4 -9.4424 6

SHREWSBURY STEPHEN B - Officer CHIEF MEDICAL OFFICER

2021-09-22 16:57:49 -0400 2021-09-21 M 4,650 d 541 direct

SHREWSBURY STEPHEN B - Officer CHIEF MEDICAL OFFICER

2021-09-22 16:57:49 -0400 2021-09-21 M 4,650 $2.46 a 19,430 direct -3.1227 -9.4424 5.2788 4 -9.4424 6

SHREWSBURY STEPHEN B - Officer CHIEF MEDICAL OFFICER

2021-09-22 16:57:49 -0400 2021-09-21 M 14,780 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
IMPEL NEUROPHARMA INC IMPL 2021-10-22 22:15:03 UTC -25.8091 25.8791 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 21:45:03 UTC -25.6803 25.7503 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 21:15:03 UTC -25.6803 25.7503 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 20:45:03 UTC -25.4737 25.5437 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 20:15:03 UTC -25.4737 25.5437 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 19:45:03 UTC -25.4737 25.5437 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 19:15:03 UTC -25.4737 25.5437 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 18:45:03 UTC -25.1931 25.2631 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 18:15:03 UTC -25.1931 25.2631 20000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 17:45:03 UTC -25.1931 25.2631 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 17:15:03 UTC -25.1931 25.2631 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 16:45:03 UTC -28.2889 28.3589 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 16:15:04 UTC -28.2889 28.3589 15000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 15:45:03 UTC -28.2889 28.3589 10000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 15:15:03 UTC -28.2889 28.3589 10000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 14:45:03 UTC -28.2889 28.3589 10000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 14:15:03 UTC -28.2889 28.3589 10000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 13:45:03 UTC -28.2889 28.3589 10000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 13:15:03 UTC -28.2889 28.3589 10000
IMPEL NEUROPHARMA INC IMPL 2021-10-22 12:45:03 UTC -28.2889 28.3589 10000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments